Status:
UNKNOWN
Retrospective Study for Description of The Use Of Omalizumab In Patients With Difficult To Control Asthma
Lead Sponsor:
Fiks, Iara Nely, M.D.
Conditions:
Asthma
Eligibility:
All Genders
18-70 years
Brief Summary
The purpose of this study is do describe the experience in the use of omalizumabe, in a real life scenario, in uncontrolled severe asthmatic patients attended in specialist outpatient clinics, and its...
Detailed Description
Omalizumab is indicated in children over 6 years of age, with diagnosis of difficult to control asthma, presenting a component of atopy demonstrated preferably positive skin tests (prick test) or in v...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients on optimal asthma treatment, good compliance and no response to treatment according to asthma consensus (GINA/NAEEP and the Latinamerican Consensus for Difficult to treat Asthma)
Exclusion
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01397760
Start Date
August 1 2011
End Date
September 1 2011
Last Update
July 20 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iara Nely Fiks
São Paulo, São Paulo, Brazil, 04508011